Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nextcure Inc
(NQ:
NXTC
)
1.290
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nextcure Inc
< Previous
1
2
3
4
Next >
NextCure Provides Year-End Clinical Pipeline Updates
December 14, 2023
From
NextCure
Via
GlobeNewswire
NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023
From
NextCure
Via
GlobeNewswire
NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML
November 15, 2023
From
NextCure
Via
GlobeNewswire
NextCure, LegoChem Biosciences Ink Collaborative Pact For Antibody Drug Conjugates
November 16, 2022
Via
Benzinga
NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results
November 02, 2023
From
NextCure
Via
GlobeNewswire
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)
October 17, 2023
Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting
From
NextCure
Via
GlobeNewswire
NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease
September 26, 2023
From
NextCure
Via
GlobeNewswire
A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC
September 12, 2023
From
NextCure
Via
GlobeNewswire
NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
September 07, 2023
From
NextCure
Via
GlobeNewswire
Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease
September 05, 2023
From
NextCure
Via
GlobeNewswire
NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 31, 2023
From
NextCure
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
August 03, 2023
From
NextCure
Via
GlobeNewswire
NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
June 21, 2023
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 13, 2023
Via
Benzinga
NextCure to Present at the JMP Securities Life Sciences Conference
May 09, 2023
From
NextCure
Via
GlobeNewswire
NextCure Provides Business Update and Reports First Quarter 2023 Financial Results
May 04, 2023
From
NextCure
Via
GlobeNewswire
NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
NextCure
Via
GlobeNewswire
NextCure Provides Business Update and Reports Full Year 2022 Financial Results
March 02, 2023
From
NextCure
Via
GlobeNewswire
NextCure to Present at SVB Securities Global Biopharma Conference
February 07, 2023
From
NextCure
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
On Tuesday, 89 companies set new 52-week lows.
Via
Benzinga
NextCure to Present at Upcoming Investor Conferences
November 22, 2022
From
NextCure
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
On Monday, 79 companies reached new 52-week lows.
Via
Benzinga
NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
November 15, 2022
From
NextCure
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
November 10, 2022
During Thursday's session, 97 companies made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 07, 2022
Gainers
Via
Benzinga
NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial in Progress Poster for NC410 Combo at the 2022 Society for Immunotherapy of Cancer Annual Meeting
November 07, 2022
From
NextCure
Via
GlobeNewswire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.